Abstract
Outcome measures in rheumatoid arthritis (RA) are important in both the clinical situation and in the evaluation of new treatments. The most appropriate clinical measures for use in these settings and the current opinion regarding how these measures may be improved was recently discussed at the 12th Annual General Meeting of the British Society for Rheumatology [Glasgow, UK; April 1995].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
